Kinapse Evaluates Pharma Opportunities in China
London, UK (PRWeb) March 11, 2007 -- Is Chinese pharma investment delivering results? What is the Chinese R&D opportunity and how can global pharmaceutical companies seize it?
These questions have been addressed in a recently published Kinapse White Paper. Commenting on the paper, Andy Black, the Kinapse Chief Executive said "This paper presents a balanced assessment of China's potential as a source of advantage to global pharmaceutical companies. Like with India and other emerging markets, there is a risk of hype overtaking reality - I believe we have taken a measured look at the opportunities, as well as the risks, and provided an insightful summary."
Shalabh Kumar, Chief Operating Officer remarked "I am pleased to release this paper as many of our clients are evaluating the relative merits of China and India for R&D operations. We have previously published a paper on opportunities for pharmaceutical companies in India, and have now brought China to the fore in this analysis. I believe the paper is strengthened by the insights brought by James Man, a Senior Analyst in our London office, and Rohit Jain, an Analyst based in India, both of whom drew upon their networks in the respective countries in completing the research".
This White Paper and others are available at www.kinapse.com/WhitePapers. and on request in hard copy.
About Kinapse
Kinapse provides specialist information processing services and business consulting to life sciences R&D organisations at unmatched value.
Kinapse has a novel operating model that allows it to bring together the very best people in virtual teams, in a wide range of R&D domains, committed to the success of our clients. The delivery model is differentiated from conventional R&D services companies by:
- Blended onshore-offshore teams, tailored to client requirements;
- Industry-veteran consulting partners who bring deep experience and expertise in specific functional areas;
- Exclusive service partners with distinctive, complementary services.
Kinapse personnel have worked with many of the world's top pharmaceutical and biotechnology companies in consulting and information processing engagements.
Contact
James Man
W: www.kinapse.com
P: +44 208 946 7600
Kinapse Ltd.
Tuition House,
27-37 St George's Road,
Wimbledon,
London SW19 4EU
###
Related Articles:
FeaturePlan and Ryma Technology Solutions Expand The Product Management View Blog; Becomes Largest Resource for Product Management Professionals
Growing Webinar Library and Ongoing Blog Create a Community of Learning and Knowledge Sharing -- Enables Software Product Managers to Communicate Experiences and Improve Product Innovation and Management
American Association for People with Disabilities and Allsup Team to Deliver Tax Information via AAPD Justice for All Blog
Tax column series geared to address tax issues for people with disabilities; invites readers' tax questions.
Controversy over CVD Screening Debated in Op-Ed, Blog and Symposia Heart Attack Eradication Advocates Challenge Critics in the Cleveland Clinic Journa
The Society for Heart Attack Prevention and Eradication (SHAPE) announced several public education efforts to further the cause of preventive heart attack screening. The efforts include a new blog and a symposia on the groundbreaking SHAPE Guideline. The blog is intended to allow cardiovascular specialist to dialogue with each other on atherosclerotic plaque, vulnerable patients and the fight against heart attack. The first symposia will be held in Orlando, Florida as a satellite event to the American Heart Association's convention and is titled, Coronary Heart Disease Risk Stratification: Dealing with the Vulnerable Patient. The announcements coincide with an op-ed published in the esteemed Cleveland Clinic Journal of Medicine entitled: V...
China Media Booms
No one really knows how many television stations there are in China. Best estimates put the number at 5,000.
The Three Reasons Your Small Business Needs A Blog
Just a few short years ago hardly anyone knew what a blog was, but now, because they are so easy to set up and maintain, their popularity has blossomed beyond all expectations. Blogs are not just for ordinary people who wish to expound on their hobby or area of special interest. Blogs are for the smart small businessperson who understands the power of the published word online.
LegalView Offers Mesothelioma Blog Readers Details of Disconcerting Request to Decrease Asbestos Regulations from Industry
LegalView informed mesothelioma blog readers of an potentially troubling request by automotive, chemical and mining industries' paid researchers to "water down" asbestos regulations. The industry-hired scientists argued that asbestos is no longer as dangerous, even though several international health organizations have declared no safe level of the material.
DCA's Articles Make China RoHS the "Topic of the Year" -- Attend the Webinar on January 18, 2007
Design Chain Associates, LLC, the premier product-focused environmental compliance company, is proud to announce that CMP Media's Green SupplyLine website (www.GreenSupplyLine.com), which focuses on tracking environmental requirements around the world for the electronics industry, has named "China RoHS" the Topic of the Year, based on the number of views of all articles posted.
JumpFly Launches PPC Advertising Blog
JumpFly launched its new PPC Advertising Blog, featuring the latest PPC Advertising news, features, tips, strategies and more. Learn from the PPC industry's most experienced and knowledgeable PPC professionals.
Chinese Medicine For Celiac
The Celiac disease is a problem with digestion It is triggered by gluten, the protein found in pizza crusts, cookies, pasta, and breads
Insolvency And Corparate Bankruptcy In China
Insolvency